British International Investment

Kelix Bio Limited

EgyptIndiaMoroccoNorth AfricaSouth AsiaConsumer - Health

Kelix Bio (formerly Zanzibar Pharma) is a specialty generic pharmaceuticals business focused on emerging markets. The company aims to develop and commercialise affordable products in countries historically deprived of access to such medications.

Investments made by BII in this company:

Investment name Commitment Region Sector Start date Status
Investment 01 $100m Consumer - Health June 2020 Active
Investment 02 $50m Consumer - Health January 2022 Active

Subscribe to receive our latest news and updates